UPDATE: Morgan Stanley Reiterates on athenahealth on Mixed Factors
In a report published Monday, Morgan Stanley analyst Ricky R. Goldwasser reiterated an Equal-Weight rating on athenahealth (NASDAQ: ATHN), but removed the $133.00 price target.
In the report, Morgan Stanley noted, “First clients for Coordinator Enterprise offering announced, Steward Healthcare, a mid-sized health system (11 hospitals, ~2,100 beds, net oper. revs. of $1.9B and Griffin Hospital (160 bed hospital, with net oper. revs of $130M). Initially, early adopter revenue model is subject to at-risk outcomes, tied to ROI and measured savings metrics. If proof-of-concept materializes, at ATHN's stated goal pricing of 1% of revenues, we estimate these contracts would amount to ~$20M in annual revenues. According to management, measurable outcome data will be available within first 12 month of contract.”
athenahealth closed on Thursday at $145.58.
Latest Ratings for ATHN
|Jul 2016||Morgan Stanley||Maintains||Overweight|
|Jul 2016||Deutsche Bank||Downgrades||Buy||Hold|
|Feb 2016||Leerink Swann||Maintains||Market Perform|
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.